Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMVWEN3)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Hepsulfam; 1,7-Heptanediol disulfamate; 96892-57-8; Sulfamic acid, 1,7-heptanediyl ester; 7-sulfamoyloxyheptyl sulfamate; heptane-1,7-diyl disulfamate; NSC 329680; Sulfamic acid 7-sulfamoyloxy-heptyl ester; UNII-971DU2GQ51; CHEMBL182440; GOJJWDOZNKBUSR-UHFFFAOYSA-N; 971DU2GQ51; sulfamic acid 1,7-heptanediyl ester; NSC329680; NSC-329680; AC1L2P3I; AC1Q6YA4; 1,7-Heptanediol bissulfamate; SCHEMBL5409150; C7H18N2O6S2; CTK8D8639; DTXSID90242619; ZINC1574758; HY-U00095; BDBM50154471; CS-7131; SULFAMIC ACID,7-HEPTANEDIYL ESTER
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||||||||